In Depth: Interviews for Prostate Cancer Awareness

1 1 1 1 1 1 1 1 1 1

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

 

Dr. Mary Harris interviewed two dynamic individuals for Prostate Cancer Awareness month: Dr. Kneeland Youngblood and Dr. Stuart Holden. Prostate cancer rates among African-American men are disproportionately high. Increasing awareness and screening is needed. These interviews may also be downloaded for FREE as podcasts in the iTunes store.

 

Youngblood.jpgKneeland Youngblood has extensive investment experience currently serving as a director of Starwood Hotels and Lodging, the Burger King Corporation, Gap Inc. and Energy Future Holdings Corp. (the $45 billion buyout of TXU). Mr. Youngblood was chairman of the American Beacon Funds, a $30 billion mutual fund company, and worked on the buyout that Pharos did with TPG of American Beacon Advisors, an asset holding company that had $44.7 billion in assets under management as of October 31, 2011. American Beacon Advisors was an investment affiliate of American Airlines. Mr. Youngblood graduated from Princeton University with an A.B in Politics/Science in Human Affairs and earned an M.D. degree from the University of Texas, Southwestern Medical School. He is a member of the Council on Foreign Relations. Mr. Youngblood is based out of the firm's Dallas office.

To listen to the interview with Dr. Youngblood, select the "Listen to Audio" box above, or click here.

 

 

 

 

 

 

skip_holden.jpgDr. Holden is a founding partner in Tower Urology, and has been an attending surgeon at Cedars-Sinai Medical Center since 1978. His expertise is urological oncology.

Since 1993, Dr. Holden has been Medical Director of the Prostate Cancer Foundation, the largest private funder of prostate cancer research in the world. In the year 2000, he became the first holder of the Warshaw Robertson Law Chair in Prostate Cancer and Director of the Warshaw Prostate Cancer Center at Cedars-Sinai Medical Center.

He is currently the Co-PI of the National Proactive Surveillance Network for patients with prostate cancer who choose no initial treatment. Dr. Holden is co-founder of Proquest Investments, a billion dollar healthcare venture capital fund, and sits on the board of several of its portfolio companies.

Dr. Holden received his bachelors degree in philosophy at the University of Wisconsin and his medical degree from Cornell University Medical College. He completed his surgical internship and residency at New York Hospital/Cornell University Medical Center and a urologic residency at Emory University. At Memorial Sloan Kettering Cancer Center, he completed two fellowships, one in urology and one in developmental genetics. During this period, he was awarded the Clinical Fellowship from the American Cancer Society.

To listen to the interview with Dr. Holden, click here.

 

 

Care to Comment?

It's Ok to be anonymous.

Required but it will not display


We will moderate comments so there will be a delay in the post of your comment.
Please revisit to see what others have said.


Security code
Refresh
Please input the anti-spam code that you can read in the image.